Abstract
Introduction
Oocyte cryopreservation is a useful tool for preserving the fertility of cancer patients at risk of losing ovarian function due to undergoing potentially sterilising therapies. Results obtained with different cryopreservation protocols have been disappointing, particularly those obtained with slow cooling procedures. The efficacy of vitrification as an application in clinical practice has recently been demonstrated. The aim of this study is to report results obtained with the Cryotop method of oocyte vitrification in a population of healthy women and to point out its potential usefulness for fertility preservation in oncological patients.
Materials and methods
The study population consisting of non-oncological patients included 47 oocyte donors and 57 recipients undergoing an oocyte donation cycle of assisted reproductive technology (ART). A total of 693 mature metaphase II oocytes were collected following ovarian stimulation using long protocol down-regulation plus gonadotropin administration. Vitrification was carried out by means of the Cryotop method. Oocytes were donated to a compatible recipient after endometrial preparation.
Results
Of the 693 oocytes, 666 (96.1%) survived. A total of 487 (73.1%) were fertilised successfully. One hundred and seventeen embryos were transferred to 57 recipients. Pregnancy rate per transfer and implantation rates were 63.2% and 38.5% respectively. Twenty-eight healthy babies were later born.
Conclusions
Oocyte cryo-banking by means of the Cryotop vitrification method represents a viable option for healthy women, producing excellent survival rates and a clinical outcome similar to that obtained with fresh oocytes. This approach could potentially be used in cancer patients who want to safeguard their fertility. Cancer patients could potentially benefit from this approach by storing their oocytes before the onset of the oncological therapy.
Similar content being viewed by others
References
Akar M, Oktay K (2005) Restoration of ovarian endocrine function by ovarian transplantation. Trends Endocrinol Metab 16:374–380
Lee SJ, Schover LR, Partridge AH et al (2006) American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. J Clin Oncol 24:2917–2931
Wallace WH, Anderson RA, Irvine DS (2005) Fertility preservation for young patients with cancer: who is at risk and what can be offered? Lancet Oncol 6:209–218
Apperley JF, Reddy N (1995) Mechanism and management of treatment-related gonadal failure in recipients of high dose chemoradiotherapy. Blood Rev 9:93–116
Yap JK, Davies M (2007) Fertility preservation in female cancer survivors. J Obstet Gynaecol 27:390–400
Sanchez M, Alama P, Gadea B et al (2007) Fresh human orthotopic ovarian cortex transplantation: long-term results. Hum Reprod 22:786–791
Oktay K, Buyuk E, Veeck L et al (2004) Embryo development after heterotopic transplantation of cryopreserved ovarian tissue. Lancet 363:837–840
Oktay K, Karlikaya G (2000) Ovarian function after transplantation of frozen, banked autologous ovarian tissue. N Engl J Med 342:1919
Mandelbaum J, Belaisch-Allart J, Junca AM et al (1998) Cryopreservation in human assisted reproduction is now routine for embryos but remains a research procedure for oocytes. Hum Reprod 13[Suppl 3]:161–174; discussion 175–177
Wang JG, Douglas NC, Dicken C et al (2007) Cryopreservation of supernumerary high quality embryos predicts favorable outcomes for patients undergoing repeated cycles of in vitro fertilization. Fertil Steril 89:368–374
Freemann L, Trounson A, Kirby C (1986) Cryopreservation of human embryos: progress on the clinical use of the technique in human in vitro fertilization. J In Vitro Fert Embryo Transf 3:53–61
Oktay K, Buyuk E, Libertella N et al (2005) Fertility preservation in breast cancer patients: a prospective controlled comparison of ovarian stimulation with tamoxifen and letrozole for embryo cryopreservation. J Clin Oncol 23:4347–4353
Kuwayama M, Vajta G, Kato O, Leibo SP (2005) Highly efficient vitrification method for cryopreservation of human oocytes. Reprod Biomed Online 11:300–308
Cobo A, Kuwayama M, Perez S et al (2007) Comparison of concomitant outcome achieved with fresh and cryopreserved donor oocytes vitrified by the Cryotop method. Fertil Steril, Epub ahead of print
Soares SR, Troncoso C, Bosch E et al (2005) Age and uterine receptiveness: predicting the outcome of oocyte donation cycles. J Clin Endocrinol Metab 90:4399–4404
Remohi J, Gutierrez A, Cano F et al (1995) Long oestradiol replacement in an oocyte donation programme. Hum Reprod 10:1387–1391
Woods EJ, Benson JD, Agca Y, Critser JK (2004) Fundamental cryobiology of reproductive cells and tissues. Cryobiology 48:146–156
Mazur P (2004) Principles of cryobiology. In: Fuller B, Lane M, Benson E (eds) Life in the frozen state. CRC Press, New York, pp 4–55
Oktay K, Cil AP, Bang H (2006) Efficiency of oocyte cryopreservation: a meta-analysis. Fertil Steril 86:70–80
Vajta G, Nagy ZP (2006) Are programmable freezers still needed in the embryo laboratory? Review on vitrification. Reprod Biomed Online 12:779–796
Liebermann J, Dietl J, Vanderzwalmen P, Tucker MJ (2003) Recent developments in human oocyte, embryo and blastocyst vitrification: where are we now? Reprod Biomed Online 7:623–633
Vajta G, Kuwayama M (2006) Improving cryopreservation systems. Theriogenology 65:236–244
Kuwayama M, Cobo A, Vajta G, (2007) Vitrification of oocytes: general considerations and the use of Cryotop method. In: Vitrification in assisted reproduction. A user’s manual and trouble shooting guide. Tucker M, Liebermann J eds. Informa health care 119:128
Martino A, Songsasen N, Leibo SP (1996) Development into blastocysts of bovine oocytes cryopreserved by ultra-rapid cooling. Biol Reprod 54:1059–1069
Liebermann J, Nawroth F, Isachenko V et al (2002) Potential importance of vitrification in reproductive medicine. Biol Reprod 67:1671–1680
Lane M, Gardner DK (2001) Vitrification of mouse oocytes using a nylon loop. Mol Reprod Dev 58:342–347
Matsumoto H, Jiang JY, Tanaka T et al (2001) Vitrification of large quantities of immature bovine oocytes using nylon mesh. Cryobiology 42:139–144
Papis K, Shimizu M, Izaike Y (2000) Factors affecting the survivability of bovine oocytes vitrified in droplets. Theriogenology 54:651–658
Vajta G, Holm P, Kuwayama M et al (1998) Open Pulled Straw (OPS) vitrification: a new way to reduce cryoinjuries of bovine ova and embryos. Mol Reprod Dev 51:53–58
Kuwayama M (2007) Highly efficient vitrification for cryopreservation of human oocytes and embryos: the Cryotop method. Theriogenology 67:73–80
Katayama KP, Stehlik J, Kuwayama M et al (2003) High survival rate of vitrified human oocytes results in clinical pregnancy. Fertil Steril 80:223–224
Ruvalcaba L, Marínez R, Cuneo S et al (2005) Improving donor programs with an oocyte bank using vitrification. Fertil Steril 84[Suppl 1]:S70
Lucena E, Bernal DP, Lucena C et al (2006) Successful ongoing pregnancies after vitrification of oocytes. Fertil Steril 85:108–111
Antinori M, Licata E, Dani G et al (2007) Cryotop vitrification of human oocytes results in high survival rate and healthy deliveries. Reprod Biomed Online 14:72–79
Bianchi V, Coticchio G, Distratis V et al (2007) Differential sucrose concentration during dehydration (0.2 mol/l) and rehydration (0.3 mol/l) increases the implantation rate of frozen human oocytes. Reprod Biomed Online 14:64–71
Levi Setti PE, Albani E, Novara PV et al (2006) Cryopreservation of supernumerary oocytes in IVF/ICSI cycles. Hum Reprod 21:370–375
Yoon TK, Kim TJ, Park SE et al (2003) Live births after vitrification of oocytes in a stimulated in vitro fertilization-embryo transfer program. Fertil Steril 79:1323–1326
Liebermann J, Tucker MJ, Sills ES (2003) Cryoloop vitrification in assisted reproduction: analysis of survival rates in > 1000 human oocytes after ultra-rapid cooling with polymer augmented cryoprotectants. Clin Exp Obstet Gynecol 30:125–129
Selman H, Angelini A, Barnocchi N et al (2006) Ongoing pregnancies after vitrification of human oocytes using a combined solution of ethylene glycol and dimethyl sulfoxide. Fertil Steril 86:997–1000
Platet N, Cathiard AM, Gleizes M, Garcia M (2004) Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion. Crit Rev Oncol Hematol 51:55–67
García-Velasco JA, Moreno L, Pacheco A et al (2005) The aromatase inhibitor letrozole increases the concentration of intraovarian androgens and improves in vitro fertilization outcome in low responder patients: a pilot study. Fertil Steril 84:82–87
Oktay K, Hourvitz A, Sahin G et al (2006) Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy. J Clin Endocrinol Metab 91:3885–3890
Venn A, Watson L, Bruinsma F et al (1999) Risk of cancer after use of fertility drugs with in-vitro fertilisation. Lancet 354:1586–1590
Sonmezer M, Akar ME, Oktay K (2005) Strong family history in women who were diagnosed with breast cancer after in vitro fertilization. Fertil Steril 84[Suppl 1]:233–234
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Cobo, A., Domingo, J., Pérez, S. et al. Vitrification: an effective new approach to oocyte banking and preserving fertility in cancer patients. Clin Transl Oncol 10, 268–273 (2008). https://doi.org/10.1007/s12094-008-0196-7
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12094-008-0196-7